Tower Research Capital LLC (Trc) Lumos Pharma, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,225 shares of LUMO stock, worth $5,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,225
Previous 3,582
65.8%
Holding current value
$5,304
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LUMO
# of Institutions
33Shares Held
2.2MCall Options Held
0Put Options Held
0-
Private Advisor Group, LLC745KShares$3.22 Million0.02% of portfolio
-
Goldman Sachs Group Inc New York, NY362KShares$1.57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA244KShares$1.06 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny214KShares$925,8140.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY121KShares$522,4180.0% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $36.4M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...